{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:16:18Z","timestamp":1786994178065,"version":"build-2736575974"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.micpath.2025.107397","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T03:07:34Z","timestamp":1739934454000},"page":"107397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Molecular mechanisms of Japanese encephalitis virus infection and advances in vaccine research"],"prefix":"10.1016","volume":"201","author":[{"given":"Junyou","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.107397_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10832","article-title":"Vector-free transmission and persistence of Japanese encephalitis virus in pigs","volume":"7","author":"Ricklin","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107397_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000437","article-title":"Japanese encephalitis-a pathological and clinical perspective","volume":"3","author":"Ghosh","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2025.107397_bib3","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/JVI.00143-15","article-title":"Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection","volume":"89","author":"Li","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib4","series-title":"StatPearls","article-title":"Japanese encephalitis","author":"Simon","year":"2023"},{"key":"10.1016\/j.micpath.2025.107397_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.micpath.2025.107397_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese encephalitis: the virus and vaccines","volume":"10","author":"Yun","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2025.107397_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1501.080311","article-title":"Past, present, and future of Japanese encephalitis","volume":"15","author":"Erlanger","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107397_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/QCO.0000000000000922","article-title":"Viral meningitis and encephalitis: an update","volume":"36","author":"Gundamraj","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107397_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.micpath.2025.107397_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis--within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2025.107397_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1285472","article-title":"Japanese encephalitis vaccines: immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease","volume":"13","author":"Hegde","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2025.107397_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40794-017-0057-x","article-title":"The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine","volume":"3","author":"Connor","year":"2017","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.micpath.2025.107397_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrmicro.2016.178","article-title":"A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers","volume":"15","author":"Coureuil","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107397_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13337-015-0301-9","article-title":"Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection","volume":"27","author":"Shukla","year":"2016","journal-title":"Virusdisease"},{"key":"10.1016\/j.micpath.2025.107397_bib15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3389\/fimmu.2018.01148","article-title":"IP-10 promotes blood-brain barrier damage by inducing tumor necrosis factor alpha production in Japanese encephalitis","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.107397_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12974-023-02891-x","article-title":"Type I\/type III IFN and related factors regulate JEV infection and BBB endothelial integrity","volume":"20","author":"Zhang","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.micpath.2025.107397_bib17","article-title":"Japanese encephalitis virus NS1 and NS1' protein disrupts the blood-brain barrier through macrophage migration inhibitory factor-mediated autophagy","volume":"98","author":"Zhang","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008260","article-title":"Japanese encephalitis virus and its mechanisms of neuroinvasion","volume":"16","author":"Hsieh","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2025.107397_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2015.10.008","article-title":"Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier","volume":"38","author":"Miner","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2025.107397_bib20","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/biology10010001","article-title":"C-Type lectin CD209L\/L-SIGN and CD209\/DC-SIGN: cell adhesion molecules turned to pathogen recognition receptors","volume":"10","author":"Rahimi","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.micpath.2025.107397_bib22","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00705-014-2042-2","article-title":"Distinct usage of three C-type lectins by Japanese encephalitis virus: DC-SIGN, DC-SIGNR, and LSECtin","volume":"159","author":"Shimojima","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virol.2008.10.025","article-title":"Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus","volume":"385","author":"Das","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.107397_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.rvsc.2016.12.007","article-title":"Integrin \u03b1v\u03b23 promotes infection by Japanese encephalitis virus","volume":"111","author":"Fan","year":"2017","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.micpath.2025.107397_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1462-5822.2011.01624.x","article-title":"Vimentin binding is critical for infection by the virulent strain of Japanese encephalitis virus","volume":"13","author":"Liang","year":"2011","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.micpath.2025.107397_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/v15071589","article-title":"Interaction between hTIM-1 and envelope protein is important for JEV infection","volume":"15","author":"Liang","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107397_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/v10110630","article-title":"TIM-1 promotes Japanese encephalitis virus entry and infection","volume":"10","author":"Niu","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107397_bib28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2217\/fmb-2016-0002","article-title":"Caveolin-1-mediated Japanese encephalitis virus entry requires a two-step regulation of actin reorganization","volume":"11","author":"Xu","year":"2016","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2025.107397_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/11779322221142122","article-title":"In silico design of siRNAs for silencing CLEC5A receptor as a potential therapeutic approach against dengue and Japanese encephalitis virus infection in human","volume":"16","author":"Yasmin","year":"2022","journal-title":"Bioinf. Biol. Insights"},{"key":"10.1016\/j.micpath.2025.107397_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-031-40086-5_10","article-title":"Japanese encephalitis virus-infected cells","volume":"106","author":"Sharma","year":"2023","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.micpath.2025.107397_bib31","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00253-012-4100-6","article-title":"Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli","volume":"95","author":"Tripathi","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107397_bib32","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1080\/22221751.2020.1757388","article-title":"Ezrin is essential for the entry of Japanese encephalitis virus into the human brain microvascular endothelial cells","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.micpath.2025.107397_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1471-4159.2010.06951.x","article-title":"Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase\/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem\/progenitor cells","volume":"115","author":"Das","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.micpath.2025.107397_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04389","article-title":"Sequential conformational rearrangements in flavivirus membrane fusion","volume":"3","author":"Chao","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.micpath.2025.107397_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02336-20","article-title":"Valosin-containing protein\/p97 plays critical roles in the Japanese encephalitis virus life cycle","volume":"95","author":"Sehrawat","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virol.2016.08.013","article-title":"The ubiquitin-proteasome system is essential for the productive entry of Japanese encephalitis virus","volume":"498","author":"Wang","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.107397_bib37","doi-asserted-by":"crossref","first-page":"11871","DOI":"10.1128\/JVI.01342-15","article-title":"Dengue virus NS1 protein modulates cellular energy metabolism by increasing glyceraldehyde-3-phosphate dehydrogenase activity","volume":"89","author":"Allonso","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.virol.2010.05.020","article-title":"Nonstructural NS1 proteins of several mosquito-borne Flavivirus do not inhibit TLR3 signaling","volume":"404","author":"Baronti","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.107397_bib39","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1128\/JVI.01850-08","article-title":"Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells","volume":"83","author":"Krishna","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.1247749","article-title":"Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system","volume":"343","author":"Akey","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.micpath.2025.107397_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/bies.201400182","article-title":"Structure-guided insights on the role of NS1 in flavivirus infection","volume":"37","author":"Akey","year":"2015","journal-title":"Bioessays"},{"key":"10.1016\/j.micpath.2025.107397_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2016.02.014","article-title":"The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design","volume":"130","author":"Watterson","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107397_bib43","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1096\/fj.99-0829com","article-title":"Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction","volume":"14","author":"Jacobs","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.micpath.2025.107397_bib44","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00705-007-0969-2","article-title":"Identification and characterization of the NTPase activity of classical swine fever virus (CSFV) nonstructural protein 3 (NS3) expressed in bacteria","volume":"152","author":"Wen","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib45","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2025.107397_bib46","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.80.9.4623-4632.2006","article-title":"Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein","volume":"80","author":"Roosendaal","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib47","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1073\/pnas.0400660101","article-title":"The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation","volume":"101","author":"Choi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2025.107397_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2199-8-59","article-title":"Biochemical characterization of a recombinant Japanese encephalitis virus RNA-dependent RNA polymerase","volume":"8","author":"Kim","year":"2007","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.micpath.2025.107397_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(99)01705-6","article-title":"Identification and characterization of the RNA helicase activity of Japanese encephalitis virus NS3 protein","volume":"465","author":"Utama","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.micpath.2025.107397_bib50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bbagrm.2012.01.003","article-title":"Effect of the methyltransferase domain of Japanese encephalitis virus NS5 on the polymerase activity","volume":"1819","author":"Wang","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.micpath.2025.107397_bib51","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/s41598-023-33254-4","article-title":"Antiviral effect of melatonin on Japanese encephalitis virus infection involves inhibition of neuronal apoptosis and neuroinflammation in SH-SY5Y cells","volume":"13","author":"Kitidee","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107397_bib52","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00705-022-05481-z","article-title":"Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies","volume":"167","author":"Kumar","year":"2022","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib53","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.micpath.2025.107397_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/v14102213","article-title":"The Japanese encephalitis antigenic complex viruses: from structure to immunity","volume":"14","author":"Khare","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107397_bib55","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.micpath.2025.107397_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01417-22","article-title":"Increased cleavage of Japanese encephalitis virus prM protein promotes viral replication but attenuates virulence","volume":"10","author":"Xiong","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2025.107397_bib57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acsinfecdis.5b00066","article-title":"Flavivirus entry inhibitors","volume":"1","author":"Wang","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107397_bib58","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","article-title":"Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study","volume":"366","author":"Ohrr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2025.107397_bib59","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1016\/j.vaccine.2010.09.035","article-title":"Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: randomised controlled phase 3 trials","volume":"28","author":"Torresi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib60","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","article-title":"Japanese encephalitis: development of new candidate vaccines","volume":"4","author":"Bharati","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micpath.2025.107397_bib62","first-page":"665","article-title":"Allergic reactions to Japanese encephalitis vaccine","volume":"23","author":"Plesner","year":"2003","journal-title":"Immunol. Allergy Clin."},{"key":"10.1016\/j.micpath.2025.107397_bib63","unstructured":"2011b. Update on Japanese encephalitis vaccine for children: United States, May 2011. MMWR. Morbidity and mortality weekly report 60, 664-665."},{"key":"10.1016\/j.micpath.2025.107397_bib64","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/infdis\/jiv023","article-title":"A Japanese encephalitis vaccine from India induces durable and cross-protective immunity against temporally and spatially wide-ranging global field strains","volume":"212","author":"Singh","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107397_bib65","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/infdis\/jiz672","article-title":"Persistence of immune responses with an inactivated Japanese encephalitis single-dose vaccine, JENVAC and interchangeability with a live-attenuated vaccine","volume":"222","author":"Vadrevu","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107397_bib66","first-page":"2","article-title":"Japanese encephalitis vaccines","volume":"S1","author":"McArthur","year":"2011","journal-title":"J. Bioterrorism Biodefense"},{"key":"10.1016\/j.micpath.2025.107397_bib67","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.vaccine.2012.01.054","article-title":"Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)","volume":"30","author":"Kikukawa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib68","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.vaccine.2012.07.034","article-title":"Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK(\u00ae)V) in children","volume":"30","author":"Okada","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-200969010-00008","article-title":"Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO]","volume":"69","author":"Duggan","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.micpath.2025.107397_bib70","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1586\/erv.09.112","article-title":"Ixiaro: a new vaccine against Japanese encephalitis","volume":"8","author":"Jelinek","year":"2009","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib71","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/14760584.2013.835638","article-title":"IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis","volume":"12","author":"Jelinek","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2025.107397_bib72","unstructured":"2011a. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011. MMWR. Morbidity and mortality weekly report 60, 661-663."},{"key":"10.1016\/j.micpath.2025.107397_bib73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/CVI.00377-13","article-title":"Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain","volume":"21","author":"Miyazaki","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2025.107397_bib74","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib75","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.micpath.2025.107397_bib76","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4161\/hv.6.12.13057","article-title":"Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults","volume":"6","author":"Nasveld","year":"2010","journal-title":"Hum. Vaccines"},{"key":"10.1016\/j.micpath.2025.107397_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01990-22","article-title":"Virulence and cross-protection conferred by an attenuated genotype I-based chimeric Japanese encephalitis virus strain harboring the E protein of genotype V in mice","volume":"10","author":"Xia","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2025.107397_bib78","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0042-6822(89)90580-1","article-title":"Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses","volume":"173","author":"Matsuura","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.107397_bib79","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/JVI.74.9.4244-4252.2000","article-title":"A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice","volume":"74","author":"Chang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib80","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib81","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41541-024-00903-2","article-title":"A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge","volume":"9","author":"Harrison","year":"2024","journal-title":"NPJ vaccines"},{"key":"10.1016\/j.micpath.2025.107397_bib82","first-page":"165","article-title":"The safety and use of canarypox vectored vaccines","volume":"84","author":"Plotkin","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.micpath.2025.107397_bib83","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0264-410X(00)00191-2","article-title":"Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans","volume":"19","author":"Kanesa-thasan","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JVI.72.1.191-200.1998","article-title":"DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice","volume":"72","author":"Lin","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107397_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2009.12.023","article-title":"Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination","volume":"129","author":"Gao","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2025.107397_bib86","article-title":"Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.107397_bib87","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/1743-422X-8-382","article-title":"Comparison of immune response generated against Japanese encephalitis virus envelope protein expressed by DNA vaccines under macrophage associated versus ubiquitous expression promoters","volume":"8","author":"Ahsan","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2025.107397_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/nnm-2022-0298","article-title":"Nanoparticle vaccine based on the envelope protein domain III of Japanese encephalitis virus elicits robust protective immune responses in mice","volume":"18","author":"Yao","year":"2023","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.micpath.2025.107397_bib89","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1016\/j.vaccine.2019.07.093","article-title":"Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis","volume":"37","author":"Zhao","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107397_bib90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5694\/mja2.52090","article-title":"Japanese encephalitis virus: changing the clinical landscape of encephalitis in Australia","volume":"219","author":"Eslick","year":"2023","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.micpath.2025.107397_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/v14010114","article-title":"Effectiveness of live-attenuated genotype III Japanese encephalitis viral vaccine against circulating genotype I viruses in swine","volume":"14","author":"Fan","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107397_bib92","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11262-022-01953-1","article-title":"Genotypic characterization of Japanese encephalitis virus circulating in swine population of India: genotype-III still in dominance","volume":"59","author":"Mote","year":"2023","journal-title":"Virus Genes"},{"key":"10.1016\/j.micpath.2025.107397_bib93","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14712598.2018.1499721","article-title":"Recent developments in vaccines and biological therapies against Japanese encephalitis virus","volume":"18","author":"Barzon","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.micpath.2025.107397_bib94","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1517\/14728222.2015.1065817","article-title":"Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges","volume":"19","author":"Ishikawa","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.micpath.2025.107397_bib95","article-title":"Antiviral activity of isatis indigotica extract and its derived indirubin against Japanese encephalitis virus. Evidence-Based complementary and alternative medicine","volume":"2012","author":"Chang","year":"2012","journal-title":"eCAM"},{"key":"10.1016\/j.micpath.2025.107397_bib96","doi-asserted-by":"crossref","first-page":"16785","DOI":"10.3390\/ijms131216785","article-title":"Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus","volume":"13","author":"Johari","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107397_bib97","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.immuni.2008.11.012","article-title":"Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing","volume":"30","author":"Town","year":"2009","journal-title":"Immunity"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T22:04:14Z","timestamp":1740780254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":97,"alternative-id":["S0882401025001226"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107397","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms of Japanese encephalitis virus infection and advances in vaccine research","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107397"}}